News From Europe!: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on News From Europe!.

Press releases published on October 5, 2026

Oct. 5, 2026

Medicenna Announces Oral Presentation of Topline Data from the Phase 1/2 ABILITY-1 Study of MDNA11 at SITC 2026

Indeterminate GlobeNewswire

Oct. 5, 2026

Greenland Mines Doubles AnorTech Stake to 19.9%; Extends Critical-Minerals Platform to Smelter-Grade Alumina, Lunar Construction Materials

Indeterminate GlobeNewswire

Oct. 5, 2026

Aprea Therapeutics to Present at October Conferences

Indeterminate GlobeNewswire

Oct. 5, 2026

Wood Mackenzie connects trusted energy intelligence with Microsoft Copilot

Indeterminate GlobeNewswire

Oct. 5, 2026

ASML reports transactions under its current share buyback program

Indeterminate GlobeNewswire

Oct. 5, 2026

Orion Pharma announces first patient dosed in Phase 1/2 clinical trial of ODM-216, the company’s first biologic candidate to reach clinical testing

Indeterminate GlobeNewswire

Oct. 5, 2026

PDAOAI Opens BIO REBOOT Collaboration and Showcases Partitioned Literature Aggregation at Drug Discovery 2026

Indeterminate GlobeNewswire

Oct. 5, 2026

Revolution Medicines Begins Treating Patients in Phase 3 RASolute 309 Trial Evaluating RASONQUE™ (daraxonrasib) Plus Zoldonrasib as First-Line Treatment for Metastatic RAS G12D Pancreatic Cancer

Indeterminate GlobeNewswire

Oct. 5, 2026

Cerevance Appoints Karl Kieburtz, M.D., M.P.H., as Chief Medical Officer

Indeterminate GlobeNewswire

Oct. 5, 2026

Coveron completes SOC 2 Type II certification with zero exceptions

Indeterminate GlobeNewswire

Oct. 5, 2026

Mastercard Selects Rezolve Ai in Worldwide Reseller Agreement to Advance AI-Powered Commerce

Indeterminate GlobeNewswire

Oct. 5, 2026

Z-TEXT zk-SNARKs Messenger Opens to the Public: No Phone, No SIM

Indeterminate EIN Presswire

Oct. 5, 2026

Medela Recognised by Australian Mums with Three MumPower Approved™ Seals

Indeterminate EIN Presswire

Oct. 5, 2026

International Unitarian Organization Launches Monthly Global Reflection with Young Unitarian Niklas Weber

Indeterminate EIN Presswire

Oct. 5, 2026

HIGHCOURT Announces Expanded Legal Knowledge and MKC2 Review Capabilities

Indeterminate EIN Presswire

Oct. 5, 2026

STMicroelectronics announces status of common share repurchase program

Indeterminate GlobeNewswire

Oct. 5, 2026

Ensimmäinen potilas on saanut hoitoa Orion Pharman Faasi 1/2 -tutkimuksessa ODM-216-molekyylillä, joka on yhtiön ensimmäinen kliiniseen kehitysvaiheeseen edennyt biologinen syöpälääkeaihio

Indeterminate GlobeNewswire

Oct. 5, 2026

Northern Discovery Metals Completes Fieldwork at the Vent Copper Project

Indeterminate GlobeNewswire

Oct. 5, 2026

Vortex Energy Commissions Hydrogen and Helium Study at Robinsons River Salt Project

Indeterminate GlobeNewswire

Oct. 5, 2026

OnCusp Therapeutics Announces Positive Phase 1b Data Evaluating its CDH6-Directed Antibody-Drug Conjugate, CUSP06, in Platinum-Resistant Ovarian Cancer (PROC) Presented at Plenary Oral Session of the IGCS 2026 Annual Global Meeting

Indeterminate GlobeNewswire